Cleared Special

K092324 - SPIROPRO

K092324 is an FDA 510(k) clearance for SPIROPRO, manufactured by Viasys Healthcare GmbH. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Special 510(k) pathway after a 30-day FDA review.

K092324 · Viasys Healthcare GmbH · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2009
Decision
30d
Days
Class 2
Risk

K092324 is an FDA 510(k) clearance for the SPIROPRO. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Viasys Healthcare GmbH (Hoechberg, DE). The FDA issued a Cleared decision on September 3, 2009 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Viasys Healthcare GmbH devices

FDA 510(k) Submission Details - K092324

510(k) Number K092324 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2009
Decision Date September 03, 2009
Days to Decision 30 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 140d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 478
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K092324.
MODEL 6000 TWO PARAMETER BEDSIDE MONITOR
K091787 · Ivy Biomedical Systems, Inc. · Oct 2009
EVISION DATA MANAGEMENT SOFTWARE
K092678 · Nonin Medical, Inc. · Oct 2009
DISPOSABLE SPO2 SENSOR M1134A
K091572 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Sep 2009
CABLE, TRANSDUCER, MODEL 2400GN
K083448 · Conmed Corporation · Aug 2009
MASIMO SET REUSABLE SOFT OXIMETRY SENSORS - ADULT / PEDICATRICS, MODEL DBI/ DBIP
K090662 · Masimo Corporation · Aug 2009
MD300K1 PULSE OXIMETER
K090599 · Beijing Choice Electronic Technololgy Co., Ltd. · Jul 2009